Related Experiment Video
Updated: Jul 13, 2025

08:32
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
239
Multivariate piecewise linear regression model to predict radiosensitivity using the association with the genome-wide
Joanna Tobiasz1,2, Najla Al-Harbi3, Sara Bin Judia3
1Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland.
Frontiers in Oncology
|October 18, 2023
Summary
This study developed a machine-learning method using copy number variations (CNVs) to predict cancer cell radiosensitivity. The approach identified specific CNV markers for radio-sensitive and radio-resistant cells, aiding personalized radiotherapy.
Area of Science:
- Genomics and Bioinformatics
- Radiation Oncology
- Cancer Biomarkers
Background:
- Predicting patient response to radiotherapy is crucial for personalized cancer treatment and radiation risk assessment.
- Genome-wide copy number variations (CNVs) are being investigated as potential biomarkers for radiosensitivity.
Purpose of the Study:
- To develop a machine-learning method for stratifying radiosensitivity using CNVs.
- To identify specific CNVs associated with different levels of sensitivity to ionizing radiation.
Main Methods:
- Utilized Affymetrix CytoScan HD microarrays to analyze CNVs in 129 fibroblast cell strains.
- Measured radiosensitivity via the surviving fraction at 2 Gy (SF2).
- Applied a dynamic programming (DP) algorithm for piecewise multivariate linear regression to predict SF2 and identify related CNVs.
Main Results:
- The DP algorithm segmented cell strains into radio-sensitive (RS), normally-sensitive (NS), and radio-resistant (RR) groups.
- A 5-segment model identified C-3SFBP (MCC gene region) as a marker for RS cells and C-7IUVU (SLC1A6 gene region) for RR cells.
- Found that decreased copy number generally correlated with increased radiosensitivity.
Conclusions:
- The DP-based method effectively narrows down CNV markers for radiosensitivity prediction.
- SF2 partitioning improves estimation and identifies distinct markers, aiding in dose adjustment for radiotherapy.
- Identified CNV markers can potentially guide personalized radiotherapy by identifying patients who benefit from dose reduction or escalation.
Keywords:
Affymetrix CytoScan HD microarrayscopy number variation (CNV)dynamic programminglinear regressionradiogenomicsradiosensitivitysurviving fraction at 2 Gy (SF2)More Related Videos
Related Concept Videos
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Genome-wide Association Studies-GWAS
13.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.5K
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357

